Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja CSIS WARRANT SERIES I (CSIS-W) vs Merck Tbk. (MERK)

CSIS WARRANT SERIES ITrading
Merck Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan CSIS WARRANT SERIES I dan Merck Tbk.: CSIS WARRANT SERIES I diperdagangkan di Rp88 (kapitalisasi pasar 4,34 M, volume 24 jam 16,1 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 387,1× kapitalisasi pasar CSIS WARRANT SERIES I, dan Merck Tbk. lebih aktif diperdagangkan (33,3 rb vs 16,1 rb). Mana yang lebih baik tergantung tujuan investasimu.

CSIS-WMERK
Kapitalisasi Pasar
4,34 M1,68 T
Volume
16,1 rb33,3 rb
Lot
161333
Perputaran
1,31 jt126,46 jt
Harga Rata-rata
81,553.797,72
Nilai Transaksi
1,31 jt126,46 jt
Harga Ekuilibrium Indikatif
883.800
Volume Ekuilibrium Indikatif
19

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MERK
Lihat detail

Tentang CSIS WARRANT SERIES I

PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.

Selengkapnya di halaman CSIS-W

Tentang Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Selengkapnya di halaman MERK